ドライアイ症候群市場レポート：疾患タイプ、薬剤タイプ、製品タイプ、流通チャネル、地域別、2024年～2032年

世界のドライアイ症候群市場規模は2023年に48億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに75億米ドルに達し、2024年から2032年の間に5％の成長率（CAGR）を示すと予測しています。老年人口の増加、様々な年齢層におけるスクリーン使用時間の増加、環境汚染の増加、診断技術の最近の進歩、消費者のヘルスケア支出の増加、大衆の意識の高まり、オンライン小売部門の拡大などが、市場を推進している主な要因の一部です。

ドライアイ症候群とは、目の潤滑と栄養補給のために十分な涙を分泌する能力に影響を及ぼす病状を指します。体が乾燥に対抗しようとするため、充血、炎症、ギトギト感、涙目など、さまざまな症状を引き起こします。ドライアイ症候群は、涙の分泌量や目の表面の質を測定する複数の検査によって診断されます。治療には、市販の人工涙液、処方薬、点鼻プラグなどの外科的治療が行われます。これらの治療法は、不快感を和らげ、視覚の明瞭度を高め、眼全体の健康を改善し、患者の生活の質を高めるのに役立ちます。

最近の診断技術の進歩により、ドライアイ症候群をより正確かつ早期に特定できるようになったことが、市場の成長を促進しています。さらに、目の健康への投資意欲を示す消費者のヘルスケア支出の増加が、もう一つの成長促進要因として作用しています。さらに、大衆の間で意識が高まり、目の健康問題に関する自己診断や専門家による相談が増加していることも、市場成長にプラスの影響を与えています。さらに、眼精疲労やドライアイを助長するライフスタイルの変化を引き起こしている急速な世界化と都市化が、市場成長に好影響を与えています。さらに、オンライン小売セクターの拡大により、OTC治療薬へのアクセスが容易になり、消費者層が広がっていることも、市場成長の起爆剤となっています。これとともに、レーザー手術などの外科的治療が利用しやすくなり、価格も手ごろになっていることも、市場の成長を後押ししています。

ドライアイ症候群の市場動向と促進要因：

老年人口の増加

老人人口の増加は市場成長の重要な促進要因です。ドライアイ症候群は、自然な老化プロセスにより老年人口に多く見られ、涙を十分に分泌する目の能力に影響を与えます。さらに、世界中の国々で平均寿命が延びており、その結果、老人人口が増加しています。この変化は、ドライアイ症候群を含む加齢に関連した病状の有病率に直接的な影響を及ぼしています。その上、老人は慢性的な健康疾患にかかりやすく、これらの疾患で使用される薬には、ドライアイの症状を悪化させる副作用があることが多いです。その結果、ヘルスケアシステムはドライアイ症候群の診断サービスと治療（潤滑点眼薬、処方薬、専門的な眼科医療サービスなど）の両方に対する需要の増加に直面しています。

さまざまな年齢層で増加するスクリーン利用時間

さまざまな年齢層でスクリーン利用時間が増加していることが、ドライアイ症候群市場を刺激する大きな要因となっています。現代のライフスタイルは、スマートフォン、タブレット、コンピューター・モニターなどのデジタル画面にますます依存するようになっています。さらに、リモートワーク文化の台頭により、従業員がデジタル画面に接する機会が増え、まばたきの頻度が低下して目の乾きを引き起こしています。このほか、いくつかの研究では、若年成人におけるスクリーン使用時間の増加とドライアイ症候群の症状との間に強い関連があることが示されています。そのため、デジタル眼精疲労によるドライアイを対象とした治療に対するニーズが高まっており、デジタル眼精疲労を軽減するために設計された市販（OTC）人工涙液、処方箋治療薬、機器に対する消費者の支出が増加しています。

環境汚染の増加

環境要因もドライアイ症候群市場の拡大に重要な役割を果たしています。急速に工業化が進む地域では、汚染された空気や異常気象がドライアイ症候群の症状を悪化させています。これに伴い、大気汚染粒子は炎症を引き起こし、目のデリケートな組織に対してしばしば毒性を示すため、ドライアイの症状を誘発または悪化させています。さらに、清掃用品や塗料、その他の家庭用品から排出される揮発性有機化合物（VOC）を含むさまざまな室内汚染物質は、室内の空気の質を低下させ、目の炎症や乾燥を引き起こします。これに加えて、汚染された環境によるアレルギー反応が、アレルギーに敏感な人のドライアイ症状を誘発することもあります。さらに、環境汚染は気候変動の一因となり、気象パターンや湿度レベルを変化させます。こうした変化は涙の蒸発速度に大きく影響し、特に乾燥地域ではドライアイの症状を悪化させる。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査目的
• 利害関係者
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要産業動向

第5章 世界のドライアイ症候群市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場内訳：疾患タイプ別
• 市場内訳：薬剤タイプ別
• 市場内訳：製品別
• 市場内訳：流通チャネル別
• 市場内訳：地域別
• 市場予測

第6章 市場内訳：疾患タイプ別

• 蒸発性ドライアイ症候群
  • 市場動向
  • 市場予測
• 涙液欠乏性ドライアイ症候群
  • 市場動向
  • 市場予測

第7章 市場内訳：薬剤タイプ別

• 抗炎症薬
  • 市場動向
  • 市場予測
• 潤滑性点眼薬
  • 市場動向
  • 市場予測
• 自己血清点眼薬
  • 市場動向
  • 市場予測

第8章 市場内訳：製品別

• 液体点眼薬
  • 市場動向
  • 市場予測
• ゲル
  • 市場動向
  • 市場予測
• 液体ワイプ
  • 市場動向
  • 市場予測
• 眼軟膏
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第9章 市場内訳：流通チャネル別

• 病院薬局
  • 市場動向
  • 市場予測
• 小売薬局
  • 市場動向
  • 市場予測
• オンライン薬局
  • 市場動向
  • 市場予測

第10章 市場内訳：地域別

• 北米
  • 市場動向
  • 市場予測
• 欧州
  • 市場動向
  • 市場予測
• アジア太平洋
  • 市場動向
  • 市場予測
• 中東・アフリカ地域
  • 市場動向
  • 市場予測
• ラテンアメリカ
  • 市場動向
  • 市場予測

第11章 世界のドライアイ症候群産業SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第12章 世界のドライアイ症候群産業：バリューチェーン分析

第13章 世界のドライアイ症候群産業：ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第14章 世界のドライアイ症候群産業：価格分析

• 価格指標
• 価格構造
• マージン分析

第15章 製造プロセス製造プロセス

• 製品概要
• 原材料の必要条件
• 製造プロセス
• 主な成功要因とリスク要因

第16章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Akorn Operating Company LLC
  • Alimera Science
  • Allergan plc.
  • Auven Therapeutics
  • Bausch+Lomb Incorporated
  • GlaxoSmithKline plc
  • Nicox S.A.
  • Novartis AG
  • Otsuka Holdings Co., Ltd.
  • Santen Pharmaceutical Co., Ltd.

List of Figures

• Figure 1: Global: Dry Eye Syndrome Market: Major Drivers and Challenges
• Figure 2: Global: Dry Eye Syndrome Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2023
• Figure 4: Global: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2023
• Figure 5: Global: Dry Eye Syndrome Market: Breakup by Product (in %), 2023
• Figure 6: Global: Dry Eye Syndrome Market: Breakup by Distribution Channel (in %), 2023
• Figure 7: Global: Dry Eye Syndrome Market: Breakup by Region (in %), 2023
• Figure 8: Global: Dry Eye Syndrome Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 9: Global: Dry Eye Syndrome (Evaporative) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 10: Global: Dry Eye Syndrome (Evaporative) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 11: Global: Dry Eye Syndrome (Aqueous) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 12: Global: Dry Eye Syndrome (Aqueous) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 13: Global: Dry Eye Syndrome (Anti-inflammatory Drugs) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 14: Global: Dry Eye Syndrome (Anti-inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 15: Global: Dry Eye Syndrome (Lubricant Eye Drops) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 16: Global: Dry Eye Syndrome (Lubricant Eye Drops) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 17: Global: Dry Eye Syndrome (Autologous Serum Eye Drops) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 18: Global: Dry Eye Syndrome (Autologous Serum Eye Drops) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 19: Global: Dry Eye Syndrome (Liquid Drops) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 20: Global: Dry Eye Syndrome (Liquid Drops) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 21: Global: Dry Eye Syndrome (Gel) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 22: Global: Dry Eye Syndrome (Gel) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 23: Global: Dry Eye Syndrome (Liquid Wipes) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 24: Global: Dry Eye Syndrome (Liquid Wipes) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 25: Global: Dry Eye Syndrome (Eye Ointment) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 26: Global: Dry Eye Syndrome (Eye Ointment) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 27: Global: Dry Eye Syndrome (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 28: Global: Dry Eye Syndrome (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 29: Global: Dry Eye Syndrome (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 30: Global: Dry Eye Syndrome (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 31: Global: Dry Eye Syndrome (Retail) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 32: Global: Dry Eye Syndrome (Retail) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 33: Global: Dry Eye Syndrome (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 34: Global: Dry Eye Syndrome (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 35: North America: Dry Eye Syndrome Market: Sales Value (in Million US$), 2018 & 2023
• Figure 36: North America: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 37: Europe: Dry Eye Syndrome Market: Sales Value (in Million US$), 2018 & 2023
• Figure 38: Europe: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 39: Asia Pacific: Dry Eye Syndrome Market: Sales Value (in Million US$), 2018 & 2023
• Figure 40: Asia Pacific: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 41: Middle East and Africa: Dry Eye Syndrome Market: Sales Value (in Million US$), 2018 & 2023
• Figure 42: Middle East and Africa: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 43: Latin America: Dry Eye Syndrome Market: Sales Value (in Million US$), 2018 & 2023
• Figure 44: Latin America: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 45: Global: Dry Eye Syndrome Industry: SWOT Analysis
• Figure 46: Global: Dry Eye Syndrome Industry: Value Chain Analysis
• Figure 47: Global: Dry Eye Syndrome Industry: Porter's Five Forces Analysis
• Figure 48: Dry Eye Syndrome Manufacturing: Process Flow

List of Tables

• Table 1: Global: Dry Eye Syndrome Market: Key Industry Highlights, 2023 & 2032
• Table 2: Global: Dry Eye Syndrome Market Forecast: Breakup by Disease Type (in Million US$), 2024-2032
• Table 3: Global: Dry Eye Syndrome Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
• Table 4: Global: Dry Eye Syndrome Market Forecast: Breakup by Product (in Million US$), 2024-2032
• Table 5: Global: Dry Eye Syndrome Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
• Table 6: Global: Dry Eye Syndrome Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 7: Dry Eye Syndrome: Raw Material Requirements
• Table 8: Global: Dry Eye Syndrome Market Structure
• Table 9: Global: Dry Eye Syndrome Market: Key Players

Abstract

The global dry eye syndrome market size reached US$ 4.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5% during 2024-2032. The rising geriatric population, escalating screen time among various age groups, increasing environmental pollution, recent advancements in diagnostic techniques, rising consumer healthcare spending, heightened awareness among the masses, and expansion of the online retail sectors are some of the major factors propelling the market.

Dry eye syndrome refers to a medical condition affecting the eyes' ability to produce adequate tears for lubrication and nourishment. It causes various symptoms, such as redness, irritation, a gritty feeling, and watery eyes as the body tries to counteract the dryness. Dry eye syndrome is diagnosed through multiple tests that measure tear production and eye surface quality. Its treatment involves over-the-counter (OTC) artificial tears, prescription medications, and surgical interventions, such as punctual plugs. These treatments aid in alleviating discomfort, enhancing visual clarity, improving overall eye health, and augmenting patient's quality of life.

The recent advancement in diagnostic techniques, which have enabled more precise and earlier identification of dry eye syndrome, is propelling the market growth. Additionally, the rising consumer healthcare spending, which showcases willingness to invest in eye health, is acting as another growth-inducing factor. Furthermore, the heightened awareness among the masses, leading to an increase in self-diagnosis and professional consultations regarding eye health issues, is positively influencing the market growth. In addition, the rapid globalization and urbanization, which have caused lifestyle changes that are conducive to eye strain and dry eye conditions, are favoring the market growth. Moreover, the expansion of the online retail sector, which provides easier access to OTC treatments, thus broadening the consumer base, is catalyzing the market growth. Along with this, the increasing availability and affordability of surgical treatments, such as laser procedures, is supporting the market growth.

Dry Eye Syndrome Market Trends/Drivers:

The rising geriatric population

The rising geriatric population is an important driver for the market growth. Dry eye syndrome is more common in the geriatric population due to the natural aging process, which impacts the eye's ability to produce sufficient tears. Furthermore, countries across the globe are experiencing an increase in life expectancy, which, in turn, is increasing the geriatric population. This shift has a direct impact on the prevalence of age-related medical conditions, including dry eye syndrome. Besides this, geriatric adults are more susceptible to chronic health illnesses, and medications used for these conditions often have side effects that exacerbate dry eye symptoms. As a result, healthcare systems are facing an increased demand for both diagnostic services and treatments for dry eye syndrome, such as lubricating eye drops, prescription medications, and specialized eye care services.

The escalating screen time among various age groups

The escalating screen time across various age groups is a substantial factor fueling the dry eye syndrome market. Modern lifestyles are increasingly dependent on digital screens, such as smartphones, tablets, and computer monitors. Furthermore, the emerging remote working culture has extended the exposure of employees to digital screens, which decreases the frequency of blinking, causing dryness in the eyes. Besides this, several studies have indicated a strong association between heightened screen time and symptoms of dry eye syndrome among young adults. Therefore, the escalating need for treatments targeting digital eye strain-induced dry eye is contributing to increased consumer spending on over-the-counter (OTC) artificial tears, prescription treatments, and devices designed to reduce digital eye strain.

The increasing environmental pollution

Environmental factors also play an important role in the expansion of the dry eye syndrome market. Polluted air and extreme weather conditions in rapidly industrializing regions are exacerbating the symptoms of dry eye syndrome. In line with this, air pollution particles cause irritation and are often toxic to the eye's delicate tissues, thus inducing or aggravating dry eye symptoms. Furthermore, various indoor pollutants, including volatile organic compounds (VOCs) emitted from cleaning products, paints, and other household items, reduce indoor air quality and lead to eye irritation and dryness. Besides this, allergic reactions from polluted environments can trigger dry eye symptoms in individuals who are susceptible to allergies. Moreover, environmental pollution contributes to climate change, which can alter weather patterns and humidity levels. These changes significantly affect tear evaporation rates and exacerbate dry eye symptoms, especially in arid regions.

Dry Eye Syndrome Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global dry eye syndrome market report, along with forecasts at the global and regional levels for 2024-2032. Our report has categorized the market based on disease type, drug type, product, and distribution channel.

Breakup by Disease Type:

Evaporative Dry Eye Syndrome

Aqueous Dry Eye Syndrome

Evaporative dry eye syndrome dominates the market

The report has provided a detailed breakup and analysis of the market based on disease type. This includes evaporative dry eye syndrome and aqueous dry eye syndrome. According to the report, evaporative dry eye syndrome represented the largest segment.

Evaporative dry eye syndrome is dominating the market due to its higher prevalence compared to other types of dry eye syndrome. In this condition, the tear film's lipid layer is compromised, causing faster evaporation of tears, resulting in dryness and irritation. Furthermore, the rising lifestyle-related issues, such as prolonged digital screen usage, exacerbate the symptoms of evaporative dry eye, making it more common among both younger and geriatric populations. Additionally, the recent technological advancements, which have made the diagnosis of evaporative dry eye more straightforward and cost-effective, are contributing to the market growth. Besides this, evaporative dry eye tends to have more chronic and pronounced symptoms, making patients more likely to seek medical interventions and opt for various treatment modalities.

Breakup by Drug Type:

Anti-inflammatory Drugs

Lubricant Eye Drops

Autologous Serum Eye Drops

Anti-inflammatory drugs hold the largest share in the market

A detailed breakup and analysis of the market based on drug type has also been provided in the report. This includes anti-inflammatory drugs, lubricant eye drops, and autologous serum eye drops. According to the report, anti-inflammatory drugs represented the largest segment.

Anti-inflammatory drugs are dominating the market due to their effectiveness in treating the underlying inflammation associated with dry eye conditions. These drugs act by reducing the inflammation on the eye's surface and tear glands, offering immediate relief and promoting long-term healing. Additionally, they are suitable for treating both aqueous-deficient and evaporative types of dry eye, making them a go-to choice for healthcare providers. Furthermore, anti-inflammatory drugs have a quick onset of action and can be self-administered, making them a preferred choice for those seeking rapid and convenient relief. Besides this, continuous research and development (R&D) in anti-inflammatory medications, leading to the formulation of drugs with fewer side effects and longer-lasting relief, is contributing to the market growth.

Breakup by Product:

Liquid Drops

Gel

Liquid Wipes

Eye Ointment

Others

Liquid drops hold the largest share in the market

A detailed breakup and analysis of the market based on product has also been provided in the report. This includes liquid drops, gel, liquid wipes, eye ointment, and others. According to the report, liquid drops accounted for the largest market share.

Liquid eye drops are dominating the market as they can be quickly and easily administered by patients themselves, providing immediate relief from symptoms. This user-friendly aspect boosts their appeal, especially for people seeking a convenient and fast-acting solution to their eye discomfort. Furthermore, compared to other treatment options such as prescription drugs, surgical interventions, or specialized medical devices, OTC liquid eye drops are generally more affordable, which makes them accessible to a broader population. Additionally, liquid eye drop formulations often include lubricants, electrolytes, and occasionally anti-inflammatory or anti-allergic components that address multiple symptoms at once. Besides this, the small packaging of liquid eye drops allows users to apply them wherever and whenever symptoms arise. This convenience enhances user compliance, making it more likely for patients to adhere to treatment plans.

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Hospital pharmacies hold the largest share in the market

A detailed breakup and analysis of the market based on distribution channel has also been provided in the report. This includes hospital pharmacies, retail pharmacies, and online pharmacies. According to the report, hospital pharmacies accounted for the largest market share.

Hospital pharmacies are dominating the market due to the trust and credibility associated with hospital-based healthcare. Patients often prefer medications and treatments prescribed and dispensed within the same healthcare ecosystem, assuming a higher standard of quality and safety. Besides this, proximity to healthcare professionals provides the ability to fill prescriptions immediately following a consultation or procedure, which is highly appealing to both patients and caregivers. Additionally, hospital pharmacies have a comprehensive inventory of medications, including specialized formulations that might not be readily available at retail or online platforms. Moreover, they have trained healthcare professionals, including pharmacists specialized in ophthalmology, which ensures that patients receive expert advice on medication administration, side effects, and other treatment-related queries.

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

North America exhibits a clear dominance, accounting for the largest dry eye syndrome market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle and Africa, and Latin America. According to the report, North America accounted for the largest market share.

North America has an advanced healthcare infrastructure, which ensures easy access to specialized eye care facilities and experienced professionals. Moreover, the high standard of care encourages timely diagnosis and effective treatment, thereby boosting the market growth. Additionally, the increasing healthcare expenditure in the region, which allows individuals to seek professional medical advice and opt for advanced treatment options, is contributing to the market growth. Furthermore, the region is a hub for pharmaceutical innovation and development, which results in the early availability of new treatments and medications. Apart from this, North America has a well-regulated pharmaceutical industry, with stringent guidelines governing the safety and efficacy of medical products, including those for treating dry eye syndrome. Moreover, the escalating geriatric population, which is highly susceptible to dry eye syndrome, is favoring the market growth.

Competitive Landscape:

Leading players are heavily investing in creating new formulations, devices, and treatment methods to address different forms of dry eye syndrome more effectively. Furthermore, they are working with research institutions, other pharmaceutical companies, and healthcare providers to accelerate the development of new products and extend their market reach. Besides this, top firms are acquiring smaller companies with innovative technologies to diversify their product portfolio quickly and gain a competitive advantage. Additionally, companies are developing educational campaigns aimed at both healthcare providers and the general public to raise awareness regarding the importance of early diagnosis and effective treatment. Moreover, they are setting up manufacturing units, distribution channels, and partnerships to tap into the growing demand for dry eye treatments in various geographical regions.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Akorn Operating Company LLC

Alimera Science

Allergan plc.

Auven Therapeutics

Bausch + Lomb Incorporated

GlaxoSmithKline plc

Nicox S.A.

Novartis AG

Otsuka Holdings Co., Ltd.

Santen Pharmaceutical Co., Ltd.

Recent Developments:

In March 2022, Thea, a US-based eye care product company, completed the acquisition of multiple ophthalmic products from Akorn Operating Company LLC.

In September 2021, Bausch + Lomb Incorporated collaborated with Novaliq Gmbh to develop a new drug, NOV03, for the treatment of dry eye disease.

In August 2022, Nicox S.A. announced that it will be working on the development of NCX 4251 as a treatment for dry eye disease.

Key Questions Answered in This Report

• 1. What was the size of the global dry eye syndrome market in 2023?
• 2. What is the expected growth rate of the global dry eye syndrome market during 2024-2032?
• 3. What are the key factors driving the global dry eye syndrome market?
• 4. What has been the impact of COVID-19 on the global dry eye syndrome market?
• 5. What is the breakup of the global dry eye syndrome market based on the disease type?
• 6. What is the breakup of the global dry eye syndrome market based on the drug type?
• 7. What is the breakup of the global dry eye syndrome market based on the product?
• 8. What is the breakup of the global dry eye syndrome market based on the distribution channel?
• 9. What are the key regions in the global dry eye syndrome market?
• 10. Who are the key companies/players in the global dry eye syndrome market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Dry Eye Syndrome Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Disease Type
• 5.5 Market Breakup by Drug Type
• 5.6 Market Breakup by Product
• 5.7 Market Breakup by Distribution Channels
• 5.8 Market Breakup by Region
• 5.9 Market Forecast

6 Market Breakup by Disease Type

• 6.1 Evaporative Dry Eye Syndrome
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Aqueous Dry Eye Syndrome
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Drug Type

• 7.1 Anti-inflammatory Drugs
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Lubricant Eye Drops
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Autologous Serum Eye Drops
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Product

• 8.1 Liquid Drops
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Gel
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Liquid Wipes
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Eye Ointment
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by Distribution Channel

• 9.1 Hospital Pharmacies
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Retail Pharmacies
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Online Pharmacies
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Europe
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Asia Pacific
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast
• 10.4 Middle East and Africa
  • 10.4.1 Market Trends
  • 10.4.2 Market Forecast
• 10.5 Latin America
  • 10.5.1 Market Trends
  • 10.5.2 Market Forecast

11 Global Dry Eye Syndrome Industry: SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Global Dry Eye Syndrome Industry: Value Chain Analysis

13 Global Dry Eye Syndrome Industry: Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Global Dry Eye Syndrome Industry: Price Analysis

• 14.1 Price Indicators
• 14.2 Price Structure
• 14.3 Margin Analysis

15 Manufacturing Process

• 15.1 Product Overview
• 15.2 Raw Material Requirements
• 15.3 Manufacturing Process
• 15.4 Key Success and Risk Factors

16 Competitive Landscape

• 16.1 Market Structure
• 16.2 Key Players
• 16.3 Profiles of Key Players
  • 16.3.1 Akorn Operating Company LLC
  • 16.3.2 Alimera Science
  • 16.3.3 Allergan plc.
  • 16.3.4 Auven Therapeutics
  • 16.3.5 Bausch + Lomb Incorporated
  • 16.3.6 GlaxoSmithKline plc
  • 16.3.7 Nicox S.A.
  • 16.3.8 Novartis AG
  • 16.3.9 Otsuka Holdings Co., Ltd.
  • 16.3.10 Santen Pharmaceutical Co., Ltd.